GSK163929
Product Specifications
CAS Number
716354-04-0
Target
HIV Protease, CCR
Related Pathways
Microbiology/Virology, GPCR/G Protein, Immunology/Inflammation, Proteases/Proteasome
Bioactivity
GSK163929 (compound 122) is an orally active CCR5 antagonist with anti-HIV properties and demonstrates low inhibitory potency against hEGR. Administered at a dosage of 2000 mg/kg/day (i.v., 7 d), it shows no adverse effects in rats, and at 250 mg/kg/day (i.v., 7 d), it is similarly non-toxic in dogs.
Smiles
C(CN1[C@@]2(C[C@H](C[C@]1(CC2)[H])N3C=4C(N=C3C)=CC=CC4)[H])C5(CCN(C(=O)C6=CC(S(NC)(=O)=O)=C(F)C=C6Cl)CC5)C7=CC(F)=CC=C7
Molecular Formula
C36H40ClF2N5O3S
Molecular Weight
696.25
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP3-28287-1mg 1 mg
CHO Monoclonal IGF-I/IGF-1 Antibody (xentuzumab) - Humanized - (Dry Ice)
Sign In for Pricing
View Details